Physicians may now be better at detecting breast cancer than ever before, but much more work remains to ensure accurate diagnosis is possible and especially to assess future risk. That's why researchers from Germany have been working to develop a new test of gene action to predict cancer risk both at first diagnosis and into the future. In a new research report appearing in the December 2012 issue of The FASEB Journal, researchers show that the various genetic switches, which are turned on and off in the regular development of every cell in the body, can be analyzed in minute detail to determine the presence or risk of breast cancer growth.
"We hope that our results help to develop tools to identify breast cancer patients when tumors are still small, and eventually curable," said Clarissa Gerhauser, Ph.D., a researcher involved in the work from the Division of Epigenomics and Cancer Risk Factors at the German Cancer Research Center in Heidelberg, Germany. "These tools might hopefully also help to predict the progression of tumor development and guide decisions on cancer treatment."
To make this advance, Gerhauser and colleagues extracted DNA from 10 small tumor tissue samples and 10 normal breast tissues from breast cancer patients. They made small fragments from the extracted DNA and identified the genetic switches within those fragments. By comparing the results from various combinations of DNA fragments, scientists discovered which switches were more prevalent in tumor tissue than in normal breast tissue. The methods used to quantify the switches are extremely sensitive, making it feasible that small biopsies would be sufficient for analysis and testing.
"This is a milestone. The method described detects activity at the genetic level, which often occurs well before any outward symptoms occur," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "Not only could this allow for earlier diagnosis of breast cancer and more accurate risk assessment, but eventually, this technique might be used in other types of cancer as well."
Federation of American Societies for Experimental Biology: http://www.faseb.org
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
When you’re the size of a human, you worry about lions and tigers and bears. But if you’re …
An amateur fossil hunter has unearthed a 7ft skeleton of a carnivorous marine reptile on a beach in south Wales.
European regulators have recommended approval of the first medicine containing stem cells to treat a rare condition caused by burns to the eye.
Ecologists say birds could hear the oncoming storm from over 100 miles away
Marine scientists plumbing the deepest part of the ocean sent microphones and collection probes baited with chicken to the bottom of a trench near Guam. Now they watch, wait ... and listen.
Lead author of two retracted papers resigns her position after failing to reproduce new approach to generating stem cells
The winners of the 2014 Olympus BioScapes Digital Imaging Competition capture a rat brain, the mouthparts of a vampire moth and other small wonders
By analysing brain activity linked to hand and arm movements, a team has created a robotic arm that a paralysed woman can control with her thoughts
Adding laser tips to ordinary shoes can improve the stride and pace of people with Parkinson's disease
Technique could someday help repair injuries